Search research articles
Contact Us
Filters
Showing results (851-860 of 1,834) with videos related to
Page
of 184
Sort By:
Mabs
|
June 6, 2024
Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG<sub>1</sub> antibodies
Wen-Ting K Tsai, Yinyin Li, Zhaojun Yin, et al.
Mabs
|
May 15, 2024
Predicting the clinical subcutaneous absorption rate constant of monoclonal antibodies using only the primary sequence: a machine learning approach
Ronghua Bei, Justin Thomas, Shiven Kapur, et al.
Mabs
|
December 2, 2025
A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training
Ammar Arsiwala, Rebecca Bhatt, Lood van Niekerk, et al.
Mabs
|
November 25, 2025
Energy-based generative models for monoclonal antibodies
Paul Pereira, Hervé Minoux, Aleksandra M Walczak, et al.
Mabs
|
November 26, 2025
Discovery and characterization of two anti-PD-1 antibodies with a unique binding mechanism to human PD-1
Keyla María Gómez Castellano, Alejandra Montes Luna, Gregorio de Jesús Carballo Uicab, et al.
Mabs
|
January 3, 2024
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function
Jennifer L Schwedler, Maxwell A Stefan, Christine E Thatcher, et al.
Mabs
|
June 12, 2026
Comparison of knockdown approaches for the generation of stable cell populations expressing afucosylated antibodies
Maria Tsachaki, Andrew Samy, Mégane Peltret, et al.
Mabs
|
March 2, 2012
The cost-effectiveness of biopharmaceuticals: a look at the evidence
Andrew W Wilson, Peter J Neumann
Mabs
|
January 16, 2014
World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA
Christine Klinguer-Hamour, Pavel Strop, Dhaval K Shah, et al.
Mabs
|
October 25, 2021
Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment
Ian White, Ninkka Tamot, Rajitha Doddareddy, et al.
Page
of 184
Search research articles
Search
Showing results (851-860 of 1,834) with videos related to
Sort By:
Page
of 184
Mabs
|
June 6, 2024
Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG<sub>1</sub> antibodies
Wen-Ting K Tsai, Yinyin Li, Zhaojun Yin, et al.
Mabs
|
May 15, 2024
Predicting the clinical subcutaneous absorption rate constant of monoclonal antibodies using only the primary sequence: a machine learning approach
Ronghua Bei, Justin Thomas, Shiven Kapur, et al.
Mabs
|
December 2, 2025
A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training
Ammar Arsiwala, Rebecca Bhatt, Lood van Niekerk, et al.
Mabs
|
November 25, 2025
Energy-based generative models for monoclonal antibodies
Paul Pereira, Hervé Minoux, Aleksandra M Walczak, et al.
Mabs
|
November 26, 2025
Discovery and characterization of two anti-PD-1 antibodies with a unique binding mechanism to human PD-1
Keyla María Gómez Castellano, Alejandra Montes Luna, Gregorio de Jesús Carballo Uicab, et al.
Mabs
|
January 3, 2024
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function
Jennifer L Schwedler, Maxwell A Stefan, Christine E Thatcher, et al.
Mabs
|
June 12, 2026
Comparison of knockdown approaches for the generation of stable cell populations expressing afucosylated antibodies
Maria Tsachaki, Andrew Samy, Mégane Peltret, et al.
Mabs
|
March 2, 2012
The cost-effectiveness of biopharmaceuticals: a look at the evidence
Andrew W Wilson, Peter J Neumann
Mabs
|
January 16, 2014
World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA
Christine Klinguer-Hamour, Pavel Strop, Dhaval K Shah, et al.
Mabs
|
October 25, 2021
Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment
Ian White, Ninkka Tamot, Rajitha Doddareddy, et al.
Page
of 184